BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7719423)

  • 1. Measurement of apolipoprotein A1 in cholesterol gallstones and gallbladder bile of patients with gallstones.
    Hasegawa T; Makino I
    J Gastroenterol; 1995 Feb; 30(1):96-102. PubMed ID: 7719423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of high total protein in gallbladder bile in the formation of cholesterol gallstones.
    Jüngst D; Lang T; von Ritter C; Paumgartner G
    Gastroenterology; 1991 Jun; 100(6):1724-9. PubMed ID: 2019377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gallbladder bile proteins in patients with gallstones and normal controls].
    Zhao XT
    Zhonghua Wai Ke Za Zhi; 1990 Jul; 28(7):414-7, 446. PubMed ID: 2269048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones.
    Jüngst D; Lang T; von Ritter C; Pratschke E; Paumgartner G
    Hepatology; 1992 May; 15(5):804-8. PubMed ID: 1568721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in pigment and carbohydrate content of gallbladder bile affect accurate quantitation of total protein when using the fluorescamine method.
    Ginanni Corradini S; Yamashita G; Nuutinen H; Chernosky A; Williams C; Hays L; Shiffman ML; Walsh RM; Svanvik J; Della Guardia P; Capocaccia L; Holzbach RT
    Scand J Gastroenterol; 1997 Apr; 32(4):340-9. PubMed ID: 9140156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary proteins in patients with and without gallstones.
    Hahm JS; Sung IK; Yang SC; Rhee JC; Lee MH; Kee CS; Park KN
    Korean J Intern Med; 1992 Jan; 7(1):18-24. PubMed ID: 1477026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile.
    Fischer S; Dolu MH; Zündt B; Meyer G; Geisler S; Jüngst D
    Eur J Clin Invest; 2001 Sep; 31(9):789-95. PubMed ID: 11589721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular composition of biliary phosphatidylcholines, as related to cholesterol saturation, transport and nucleation in human gallbladder bile.
    Angelico M; Ginanni Corradini S; Masella R; Alvaro D; Cantafora A; Capocaccia L
    J Hepatol; 1992 May; 15(1-2):59-66. PubMed ID: 1506657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients.
    Keulemans YC; Mok KS; de Wit LT; Gouma DJ; Groen AK
    Hepatology; 1998 Jul; 28(1):11-6. PubMed ID: 9657090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallstone cholesterol content is related to apolipoprotein E polymorphism.
    Juvonen T; Kervinen K; Kairaluoma MI; Lajunen LH; Kesäniemi YA
    Gastroenterology; 1993 Jun; 104(6):1806-13. PubMed ID: 8500739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary nonmucin glycoproteins in patients with and without gallstones.
    Lipsett PA; Fox-Talbot MK; Falconer SD; Tam ML; Magnuson TA; Lillemoe KD; Pitt HA
    J Surg Res; 1995 Apr; 58(4):386-90. PubMed ID: 7723316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary alpha 1-acid glycoprotein concentrations in gallstone-free controls and in patients with multiple or solitary cholesterol gallstones.
    Nuutinen H; Abei M; Schwarzendrube J; Ginanni Corradini S; Walsh RM; Kawczak P; Holzbach RT
    Dig Dis Sci; 1995 Aug; 40(8):1786-91. PubMed ID: 7648981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophoretic analysis of bile proteins from patients with and without gallstones.
    Ota Y; Ido K; Kimura K; Fukui E; Ikemoto S
    Electrophoresis; 1995 Mar; 16(3):402-6. PubMed ID: 7607174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased protein concentration and improved metastability of bile induced by ursodeoxycholate.
    Chijiwa K; Hirota I; Noshiro H
    Gastroenterol Jpn; 1992 Feb; 27(1):88-94. PubMed ID: 1555751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased biliary protein precedes gallstone formation.
    Moser AJ; Abedin MZ; Roslyn JJ
    Dig Dis Sci; 1994 Jun; 39(6):1313-20. PubMed ID: 8200266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility.
    Shiffman ML; Sugerman HJ; Kellum JH; Brewer WH; Moore EW
    Int J Obes Relat Metab Disord; 1993 Mar; 17(3):153-8. PubMed ID: 8385075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of gallstones.
    Carey MC
    Recenti Prog Med; 1992; 83(7-8):379-91. PubMed ID: 1529152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary proteins and the nucleation defect in cholesterol cholelithiasis.
    Gallinger S; Harvey PR; Petrunka CN; Ilson RG; Strasberg SM
    Gastroenterology; 1987 Apr; 92(4):867-75. PubMed ID: 3556994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease.
    Groen AK; Noordam C; Drapers JA; Egbers P; Jansen PL; Tytgat GN
    Hepatology; 1990 Apr; 11(4):525-33. PubMed ID: 2328950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.